Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hopper

Showing results (491-500 of 1,167) with videos related to

Pageof 117
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2003
The HER2 I655V polymorphism and risk of breast cancer in women < age 40 yearsKaren G Montgomery, Dorota M Gertig, Simon W Baxter, et al.
JAMA Oncology|February 25, 2021
Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic VariantsYun-Hee Choi, Mary Beth Terry, Mary B Daly, et al.
Journal of Medical Genetics|June 4, 2011
Determining the frequency of de novo germline mutations in DNA mismatch repair genesAung Ko Win, Mark A Jenkins, Daniel D Buchanan, et al.
Gastroenterology|February 28, 2009
Germline MutY human homologue mutations and colorectal cancer: a multisite case-control studySean P Cleary, Michelle Cotterchio, Mark A Jenkins, et al.
Journal of the National Cancer Institute|October 19, 2000
CYP17 promoter polymorphism and breast cancer in Australian women under age forty yearsA B Spurdle, J L Hopper, G S Dite, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2013
Risk of pancreatic cancer in breast cancer families from the breast cancer family registryEvelina Mocci, Roger L Milne, Elena Yuste Méndez-Villamil, et al.
Breast Cancer Research and Treatment|June 19, 2013
Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction modelGillian S Dite, Maryam Mahmoodi, Adrian Bickerstaffe, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2015
Accuracy of self-reported nevus and pigmentation phenotype compared with clinical assessment in a population-based study of young Australian adultsAnne E Cust, Kristen M Pickles, Chris Goumas, et al.
BMC Research Notes|October 7, 2015
Tools for translational epigenetic studies involving formalin-fixed paraffin-embedded human tissue: applying the Infinium HumanMethyation450 Beadchip assay to large population-based studiesEe Ming Wong, JiHoon E Joo, Catriona A McLean, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2017
Risk of uterine cancer for BRCA1 and BRCA2 mutation carriersY C Lee, R L Milne, S Lheureux, et al.
Pageof 117

Showing results (491-500 of 1,167) with videos related to

Sort By:
Pageof 117
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2003
The HER2 I655V polymorphism and risk of breast cancer in women < age 40 yearsKaren G Montgomery, Dorota M Gertig, Simon W Baxter, et al.
JAMA Oncology|February 25, 2021
Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic VariantsYun-Hee Choi, Mary Beth Terry, Mary B Daly, et al.
Journal of Medical Genetics|June 4, 2011
Determining the frequency of de novo germline mutations in DNA mismatch repair genesAung Ko Win, Mark A Jenkins, Daniel D Buchanan, et al.
Gastroenterology|February 28, 2009
Germline MutY human homologue mutations and colorectal cancer: a multisite case-control studySean P Cleary, Michelle Cotterchio, Mark A Jenkins, et al.
Journal of the National Cancer Institute|October 19, 2000
CYP17 promoter polymorphism and breast cancer in Australian women under age forty yearsA B Spurdle, J L Hopper, G S Dite, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2013
Risk of pancreatic cancer in breast cancer families from the breast cancer family registryEvelina Mocci, Roger L Milne, Elena Yuste Méndez-Villamil, et al.
Breast Cancer Research and Treatment|June 19, 2013
Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction modelGillian S Dite, Maryam Mahmoodi, Adrian Bickerstaffe, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2015
Accuracy of self-reported nevus and pigmentation phenotype compared with clinical assessment in a population-based study of young Australian adultsAnne E Cust, Kristen M Pickles, Chris Goumas, et al.
BMC Research Notes|October 7, 2015
Tools for translational epigenetic studies involving formalin-fixed paraffin-embedded human tissue: applying the Infinium HumanMethyation450 Beadchip assay to large population-based studiesEe Ming Wong, JiHoon E Joo, Catriona A McLean, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2017
Risk of uterine cancer for BRCA1 and BRCA2 mutation carriersY C Lee, R L Milne, S Lheureux, et al.
Pageof 117